- Research works
- 79 ▲ 282% vs 2013–17
- Citations
- 586 7.4 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Argenx (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.9×. Every wedge is a field page.
- Immunology and Microbiology 5.9×
- Medicine 4.0×
- Pharmacology, Toxicology and Pharmaceutics 2.6×
- Economics, Econometrics and Finance 2.3×
- Neuroscience 2.2×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Mathematics 0.3×
- Psychology 0.2×
- Nursing 0.1×
- Arts and Humanities 0.1×
- Health Professions 0.1×
- Business, Management and Accounting 0.1×
- Chemistry 0.0×
- Environmental Science 0.0×
- Social Sciences 0.0×
- Engineering 0.0×
Who are the top researchers at Argenx (Belgium)?
Ranked on the composite score, Glenn Phillips, C. Blein and Sarah Dewilde lead among researchers whose main affiliation is Argenx (Belgium).
- 1 Glenn Phillips Belgium · #1,284,322 worldwide 21 citations · 21 works
- 2 C. Blein Belgium · #1,583,230 worldwide 0 citations · 18 works
- 3 Sarah Dewilde Belgium · #1,600,508 worldwide 13 citations · 16 works
Which keywords describe research at Argenx (Belgium)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Epidemiology, Prognosis, Neuromuscular Junction, Immunotherapy, Myasthenia Gravis, Thymic Tumors and Diagnosis.
- Autoimmunity
- Drug Development Costs
- Hereditary Spastic Paraplegia
- Charcot-Marie-Tooth Disease
- Genetics
- Genetic Mutations
- Inflammation
- Guillain-Barré Syndrome
- Pathogenesis
- Dropped Head Syndrome
- Antibody Engineering
- Parkinson's Disease
- Monoclonal Antibodies
- Immunosuppressive Therapy
- Rituximab
- Intravenous Immunoglobulin
- Diagnosis
- Myasthenia Gravis
- Immunotherapy
- Epidemiology
- Autoantibodies
- Prognosis
- Neuromuscular Junction
- Thymic Tumors
- Neurological Disorders
- Treatment
- Glycosylation
- Autoimmune
- Quality of Life
- Therapeutic Antibodies
- Camptocormia
- Fc Receptors
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Bullous Pemphigoid
- Pemphigoid
- Thrombosis
- Adrenal Insufficiency
- Corticosteroid Therapy
- Mitochondrial Dysfunction
- Generic Drugs
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Autoantibodies15▲ 110×8 topics
- Epidemiology15▲ 6.5×21 topics
- Prognosis13▲ 68×3 topics
- Immunotherapy10▲ 25×4 topics
- Neuromuscular Junction10▲ 422×2 topics
- Myasthenia Gravis10▲ 852×1 topic
- Thymic Tumors10▲ 852×1 topic
- Diagnosis8▲ 14×10 topics
- Neurological Disorders7▲ 22×7 topics
- Intravenous Immunoglobulin6▲ 161×2 topics
- Treatment6▲ 8.2×10 topics
- Rituximab5▲ 56×4 topics
- Glycosylation4▲ 64×3 topics
- Immunosuppressive Therapy4▲ 35×4 topics
- Autoimmune4▲ 132×2 topics
- Monoclonal Antibodies4▲ 69×3 topics
- Quality of Life4▲ 4.3×8 topics
- Parkinson's Disease3▲ 24×3 topics
- Therapeutic Antibodies3▲ 83×2 topics
- Antibody Engineering3▲ 102×1 topic
- Camptocormia3▲ 563×1 topic
- Dropped Head Syndrome3▲ 563×1 topic
- Fc Receptors3▲ 102×1 topic
- Pathogenesis3▲ 11×3 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy3▲ 207×1 topic
- Guillain-Barré Syndrome3▲ 207×1 topic
- Bullous Pemphigoid3▲ 198×1 topic
- Inflammation3▲ 2.4×15 topics
- Pemphigoid3▲ 198×1 topic
- Genetic Mutations2▲ 9.1×5 topics
- Thrombosis2▲ 14×4 topics
- Genetics2▲ 5.0×4 topics
- Adrenal Insufficiency2▲ 165×1 topic
- Charcot-Marie-Tooth Disease2▲ 251×1 topic
- Corticosteroid Therapy2▲ 135×1 topic
- Hereditary Spastic Paraplegia2▲ 251×1 topic
- Mitochondrial Dysfunction2▲ 9.8×2 topics
- Drug Development Costs2▲ 98×1 topic
- Generic Drugs2▲ 98×1 topic
- Autoimmunity1▲ 16×3 topics
Which research topics does Argenx (Belgium) publish most on?
By volume in 2022–2025: Myasthenia Gravis and Thymoma, Parkinson's Disease and Spinal Disorders, Monoclonal and Polyclonal Antibodies Research and Peripheral Neuropathies and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Myasthenia Gravis and Thymoma Neurology 10 works
- 2 Parkinson's Disease and Spinal Disorders Neurology 3 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 4 Peripheral Neuropathies and Disorders Neurology 3 works
- 5 Autoimmune Bullous Skin Diseases Pathology and Forensic Medicine 3 works
- 6 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 2 works
- 7 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 2 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
- 9 Cancer Treatment and Pharmacology Oncology 1 works
- 10 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Argenx (Belgium)'s research output changed?
Output in 2018–2022 was 282% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ghent
- Ghent University
- Ghent University Hospital
- HOGENT University of Applied Sciences and Arts
- Vlaams Instituut voor Biotechnologie
- Nutrition Sciences (Belgium)
- iMinds
- AZ Sint-Lucas
- VIB-UGent Center for Plant Systems Biology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.